Abstract
We report our institutional experience of the management of 2 cases of rare non-Wilms' tumors; a rhabdoid tumor in a 17-month old boy and a clear cell sarcoma in a 5-year old girl. The two patients were treated with ifosfamide/carboplatin/etoposide (ICE) alternating with vincristine/doxorubicin/cyclophosphamide (VDC) and cyclophosphamide/etoposide (CE) alternating with vincristine/doxorubicin/cyclophosphamide (VDC) and radiotherapy, respectively. Both patients showed full response with no significant adverse events. At 2-year follow up, they are disease and relapse free. Although contemporary treatment regimens are very promising, multicenter collaborative studies are needed in order to define a standard treatment for non-Wilms' tumors. © M. Kourti et al., 2012.
Author supplied keywords
Cite
CITATION STYLE
Kourti, M., Hatzipantelis, E., Zaramboukas, T., Tragiannidis, A., Petrakis, G., & Athanassiadou-Piperopoulou, F. (2012). Rare non-wilms’ tumors in children. Rare Tumors, 4(1), 16–17. https://doi.org/10.4081/rt.2012.e6
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.